# Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With Dabigatran

> **NCT01595854** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** dabigatran etexilate
- **DRUG:** Ticagrelor
- **DRUG:** Ticagrelor
- **DRUG:** dabigatran etexilate
- **DRUG:** dabigatran etexilate

## Key facts

- **NCT ID:** NCT01595854
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2013-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01595854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01595854, "Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With Dabigatran". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01595854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*